semaglutide and macular degeneration Neovascular Age-Related Among Adults with Type 2 Diabetes: An OHDSI Network Study GLP-1s May Protect Against AMD

It's been extensively studied, with numerous success stories highlighting its ability to support healthy weight loss

Pons R, Andreu AL, Checcarelli N, Vil MR, Engelstad K, Sue CM, et al

Our preliminary evaluation has not found evidence that use of these medicines causes suicidal thoughts or actions, the FDA report said

These side effects may be more common after starting therapy and after a dose increase

A single subcutaneous injection kept GH 2- to 10-fold elevated for at least 6 days and IGF-1 1.5- to 3-fold for 9-11 days , with a half-life of 5.8-8.1 days [PMID 16352683]

Beyond those four, Lilly has filed additional TRIUMPH studies